| Gene | Gene Full Name | DSI g | DPI g | pLI | Disease | Type | Score gda | EL gda | EI gda | N. PMIDs | N. SNPs gda | First Ref. | Last Ref. | ||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
|
interleukin 2 receptor subunit alpha | 0.389 | 0.885 | 5.5E-02 |
|
disease | 0.500 | None | 0.985 | 4 | 7 | 1994 | 2019 | ||||||||
|
interleukin 7 receptor | 0.487 | 0.769 | 3.8E-07 |
|
disease | 0.500 | None | 0.982 | 4 | 2 | 2003 | 2019 | ||||||||
|
C-type lectin domain containing 16A | 0.612 | 0.654 | 0.28 |
|
disease | 0.500 | None | 1.000 | 2 | 8 | 2009 | 2020 | ||||||||
|
CD58 molecule | 0.584 | 0.769 | 0.25 |
|
disease | 0.500 | None | 1.000 | 2 | 3 | 2008 | 2019 | ||||||||
|
TNF receptor superfamily member 1A | 0.409 | 0.923 | 0.99 |
|
disease | 0.500 | None | 0.970 | 2 | 2 | 1999 | 2019 | ||||||||
|
CD40 molecule | 0.396 | 0.846 | 0.85 |
|
disease | 0.500 | None | 0.958 | 1 | 1 | 2000 | 2019 | ||||||||
|
major histocompatibility complex, class II, DR beta 1 | 0.333 | 0.923 | 1.1E-03 |
|
disease | 0.500 | None | 0.923 | 1 | 3 | 1992 | 2020 | ||||||||
|
tyrosine kinase 2 | 0.505 | 0.769 | 4.5E-08 |
|
disease | 0.490 | None | 1.000 | 1 | 1 | 2009 | 2014 | ||||||||
|
kinesin family member 1B | 0.516 | 0.808 | 1.00 |
|
disease | 0.460 | None | 1.000 | 1 | 1 | 2008 | 2014 | ||||||||
|
major histocompatibility complex, class II, DR alpha | 0.581 | 0.769 | 0.52 |
|
disease | 0.440 | None | 1.000 | 1 | 10 | 1999 | 2010 | ||||||||
|
Cbl proto-oncogene B | 0.691 | 0.423 | 1.00 |
|
disease | 0.440 | None | 0.800 | 1 | 1 | 2010 | 2017 | ||||||||
|
signal transducer and activator of transcription 4 | 0.471 | 0.769 | 0.77 |
|
disease | 0.430 | None | 1.000 | 1 | 2 | 2008 | 2017 | ||||||||
|
CD6 molecule | 0.489 | 0.808 | 9.3E-05 |
|
disease | 0.420 | None | 1.000 | 2 | 1 | 2009 | 2016 | ||||||||
|
TNF alpha induced protein 3 | 0.481 | 0.808 | 1.00 |
|
disease | 0.420 | None | 1.000 | 1 | 2 | 2011 | 2015 | ||||||||
|
TNF superfamily member 14 | 0.529 | 0.769 | 5.2E-02 |
|
disease | 0.420 | None | 1.000 | 1 | 1 | 2011 | 2013 | ||||||||
|
interferon beta 1 | 0.421 | 0.846 |
|
disease | 0.400 | None | 0.958 | 5 | 0 | 1995 | 2020 | |||||||||
|
interleukin 1 beta | 0.276 | 0.962 | 0.13 |
|
disease | 0.400 | None | 0.905 | 2 | 0 | 1997 | 2019 | ||||||||
|
purinergic receptor P2X 7 | 0.450 | 0.808 | 3.3E-11 |
|
disease | 0.400 | None | 1.000 | 1 | 0 | 2007 | 2019 | ||||||||
|
vitamin D receptor | 0.352 | 0.885 | 1.7E-05 |
|
disease | 0.400 | None | 0.891 | 1 | 0 | 1999 | 2019 | ||||||||
|
major histocompatibility complex, class II, DP beta 1 | 0.453 | 0.923 | 5.3E-10 |
|
disease | 0.400 | None | 0.880 | 1 | 0 | 1990 | 2018 | ||||||||
|
interleukin 17A | 0.324 | 0.923 | 4.3E-02 |
|
disease | 0.400 | None | 0.986 | 1 | 0 | 1999 | 2020 | ||||||||
|
interleukin 1 receptor antagonist | 0.373 | 0.923 | 3.1E-02 |
|
disease | 0.400 | None | 0.722 | 1 | 0 | 1997 | 2015 | ||||||||
|
interleukin 10 | 0.281 | 0.923 | 5.9E-03 |
|
disease | 0.400 | None | 0.922 | 1 | 0 | 1996 | 2019 | ||||||||
|
NLR family pyrin domain containing 3 | 0.361 | 0.962 | 8.1E-04 |
|
disease | 0.400 | None | 1.000 | 1 | 0 | 2010 | 2019 | ||||||||
|
apolipoprotein E | 0.338 | 0.962 | 1.9E-03 |
|
disease | 0.400 | None | 0.877 | 1 | 0 | 1994 | 2019 |